EDEK, Y. C. Et Al. 2024. Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report. DERMATOLOGY PRACTICAL & CONCEPTUAL , no.4 .

EDEK, Y. C., ERTÜRK, E., & ADIŞEN, E., (2024). Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report. DERMATOLOGY PRACTICAL & CONCEPTUAL , no.4.

EDEK, YUSUF, ECEM ERTÜRK, And ESRA ADIŞEN. "Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report," DERMATOLOGY PRACTICAL & CONCEPTUAL , no.4, 2024

EDEK, YUSUF C. Et Al. "Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report." DERMATOLOGY PRACTICAL & CONCEPTUAL , no.4, 2024

EDEK, Y. C. ERTÜRK, E. And ADIŞEN, E. (2024) . "Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report." DERMATOLOGY PRACTICAL & CONCEPTUAL , no.4.

@article{article, author={YUSUF CAN EDEK Et Al. }, title={Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report}, journal={DERMATOLOGY PRACTICAL & CONCEPTUAL}, year=2024}